Description
Semax is a synthetic heptapeptide engineered from a fragment of adrenocorticotropic hormone (ACTH). Through strategic structural modifications, the peptide exhibits enhanced stability while maintaining a precisely characterized molecular profile. These properties have contributed to its prominence in peptide research and biochemical investigations.
The peptide’s compact amino acid sequence and distinct molecular architecture make it a valuable subject of study in fields focused on peptide-receptor interactions, signaling pathways, and molecular biology. Semax continues to attract scientific interest due to its unique design and extensive characterization within peptide science.
Reviews
There are no reviews yet.